Stay updated with breaking news from E Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The global paracetamol market size is estimated to grow by USD 929.4 million from 2024-2028, according to Technavio. The market is estimated to...
As a third-generation leader, Mahima has steered significant advancements in the vaccine sector.
Biological E will scale up its production capacity to potentially reach 50 million doses annually, accelerating Takeda's efforts to manufacture 100 million doses annually within the decade
/PRNewswire/ -- The paracetamol market is expected to grow by USD 791.9 million from 2022 to 2027. In addition, the momentum of the market will progress at a...
Corbevax is based on a protein sub-unit platform and manufactured by the pharmaceutical firm Biological E Limited in India.